About Brigatinib
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC)
Adult dose: | Initial dose of 90 mg once daily; may be increased to 180 mg once daily based on tolerance and clinical response
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Common side effects include nausea, diarrhea, fatigue, headache, hypertension, and increased liver enzymes
C
Drug Class
Tyrosine kinase inhibitor
Uses & Indications
Treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC)
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: Takeda Pharma A/S, DENMARK
Package Size
28's (14's Blister x 2)
Price & Supplier
Price in UAE: AED 6608.00
Dosage Information
Adult Dose
Initial dose of 90 mg once daily; may be increased to 180 mg once daily based on tolerance and clinical response
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Common side effects include nausea, diarrhea, fatigue, headache, hypertension, and increased liver enzymes
Contraindications & Precautions
Hypersensitivity to brigatinib or any component of the formulation; severe hepatic impairment
Important Warnings
Risk of interstitial lung disease (ILD) and pneumonitis; monitor for respiratory symptoms; may cause QT prolongation; liver enzyme elevations; caution in patients with a history of cardiac issues
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.